Berylson Capital Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-193,872	Closed	-$1.16M	–	21
2019 Q1	$1.16M	Buy	+193,872	New	+$1.16M	1.37%	27